Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADT vs Chemotherapy in AR-expressing Salivary Gland Cancer
NCT01969578Phase 2Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Sep 2015
- Primary completion
- Aug 2023
- Modality
- Peptides, Small Molecules
- Countries
- 8
01
Overview
A Phase 2 trial of bicalutamide, triptorelin in salivary gland cancer (SGC), sponsored by European Organisation for Research and Treatment of Cancer. Started Sep 2015; status: completed.
02
Drugs
bicalutamidetriptorelin
03
Conditions
salivary gland cancer (SGC)
Beyond the preview
Go deeper on NCT01969578.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01969578.